Anthropic Sought Data from Big Pharma, Faced Near-Unanimous Rejection
joecole · x · 2026-07-07
David Friedberg revealed that Anthropic proactively contacted major pharmaceutical companies to request proprietary data for AI R&D, but almost all declined the collaboration. This highlights the data barriers AI companies face when entering the highly regulated life sciences sector and suggests that Big Pharma maintains a strong protective stance regarding AI data partnerships. (The original post was truncated; full context is unknown.)
Related event: Anthropic Denied Data Access by Big Pharma(2 posts)→
More from Companies & People
- X drama: Anthropic researchers accused of spying on academic customers and racing them to results — basedjensen · 2026-09-11
- Investor argues Palantir-Nvidia partnership should slash Anthropic's IPO valuation — pdamodaran · 2026-09-11
- PyTorch Day Korea 2026 launches first offline conf, CFP closes Sept 13 — PyTorch · 2026-09-11
- Class action accuses Anthropic of overselling Claude subscriptions with deceptive usage multipliers — The Decoder · 2026-09-11
- AI post-training and evals jobs pay up to $850K, with median offers at $210K–$325K — FinanceYF5 · 2026-09-11
- 89% of firms use AI, only 6% see significant ROI — the busywork illusion — mikeflache · 2026-09-11